REFERENCES
- Itoh K, Yoshida S, Fukuda M. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits - critical analysis with new ultrasound technique. Jpn Circ J1994; 58: 844-854.
- Miyazaki M, Takai S. Antiatherosclerotic effect of alacepril, anangiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res 1999; 22: 49–54.
- Russell JC, Graham SE, Amy RM, Dolphin PJ. Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril. J Cardiovasc Pharmacol 1998; 31: 971–977.
- Suzuki M, Teramoto S, Katayama H, Ohga E, Matsuse T, Ouchi Y. Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages. J Asthma 1999; 36: 665–670.
- Noda Y, Anzai K, Mori A, Kohno M, Shinmei M, Packer L. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem Mol Biol Intl 997; 42: 35-44.
- Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963–20966.
- Dong ZM, Wagner DD. Leukocyte-endothelium adhesion molecules in atherosclerosis. J Lab Clin Med 1998; 132: 369–375.
- Yoshida N, Manabe H, Terasawa Yet al. Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. Biofactors 2000; 13: 279–288.
- Matsumoto K, Miyazaki H, Fujii T, Yoshida K, Amejima H, Hashimoto M. Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneimittelforschung 1986; 36: 40–46.
- Mak IT, Freedman AM, Dickens BF, Weglicki WB. Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 1990; 40: 2169–2175.
- Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol 1992; 19: 330–340.
- Cominacini L, Pasini A, Garbin U et al. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am J Hypertens 2002; 15: 891–895.
- Mira ML, Silva MM, Manso CF. The scavenging of oxygen free radicals by angiotensin-converting enzyme inhibitors: the importance of the sulfhydryl group in the chemical structure of the compounds. Ann NY Acad Sci 1994; 723: 439–441.
- Lizard G, Gueldry S, Sordet 0 et al. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 1998; 12: 1651–1663.
- True AL, Rahman A, Malik AB. Activation of NF-kappaB induced by H(2)0(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol 2000; 279: L302–L311.
- Higgins JP. Can angiotensin-converting enzyme inhibitors reverse atherosclerosis? South Med J2003; 96: 569–579.